Skip to main content

Laurion Capital Management LP

Position in LLY — ELI LILLY & Co

CIK 1390202 NEW YORK, NY

Position in LLY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$537,344
+$537,344 QoQ
Shares Held
448
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#3,700
of 4,605 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Jun 30, 2025
CallValue
$77,953,000
CallShares
100,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Laurion Capital Management LP holds $13,138,022 across 6 Drug Manufacturers - General names. LLY ranks #3 (4.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 LLY
ELI LILLY & Co
This page
448 $537,344

All Filings in LLY

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $537,344 448
2025-06-30 $77,953,000 100,000
2024-12-31 $8,337,600 10,800
2024-12-31 $231,600 300
2024-09-30 $797,346 900
2024-09-30 $2,948,408 3,328
2022-06-30 $577,777 1,782
2022-03-31 $11,604,857 40,524
2021-12-31 $24,942,666 90,300
2021-12-31 $593,044 2,147
2021-09-30 $28,553,621 123,582
2021-09-30 $42,628,725 184,500
2021-09-30 $2,148,765 9,300
2020-09-30 $12,590,285 85,058
2020-03-31 $485,520 3,500
2020-03-31 $1,581,408 11,400